In the last trading session, 1.3 million Contineum Therapeutics Inc (NASDAQ:CTNM) shares changed hands as the company’s beta touched 0.78. With the company’s per share
During the last session, Contineum Therapeutics Inc (NASDAQ:CTNM)’s traded shares were 68012.0, with the beta value of the company hitting 0.50. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne